Sponsor pipeline

CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd. clinical trial pipeline

Get alerts when CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 2/3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2/3
NCT05924776 Plasmodium Immunotherapy for Advanced Ovarian Cancer Advanced Ovarian Cancer Not Yet Recruiting 2024-07-22

Disease areas by active trials

Ovarian Cancer (1)

Get alerts when CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free